پایان نامه استخراج و تعیین مقدار Proscillaridin در پیاز عنصل بومی ایران

فهرست:

ندارد.
 

منبع:

1-Drimia maritima available from www.theplantlist.org

2-  قهرمان، احمد. مجموعه فلور رنگی ایران. تهران:موسسه جنگلها و مراتع ایران .شماره 496

3-  ابوعلی سینا. قانون در طب . ترجمه عبدالرحمن شرفکندی. تهران:انتشارات سروش ؛1368 .کتاب دوم.ص261.

4- رازی محمد بن زکریا.  الحاوی. سلیمان افشاری پور. تهران :انتشارات فرهنگستان علوم پزشکی جمهوری اسلامی ایران؛ 1384.ج 20.ص 33

5- Bozcuk H, [et al]. "Urginea maritima (L.) Baker (Liliaceae) extract induces more cytotoxicity than standard chemotherapeutics in the A549 non-small cell lung cancer (NSCLC) cell line." Turkish Journal of Medical Sciences.2011. 41(1): 101-108.

6-David heber. PDR for herbal medicines. Thomson healthcare Inc. 2007. 785-787.

7- Hesam R.EI-seed, [et al]. The traditional medical uses and cytotoxic activities of sixty-one Egyptian plants : Discovery of an active cardiac glycoside from Urginea maritima. Journal of Ethnopharmacology. 2013;145:746-757

8- Balbaa SI, Khafagy SM ,Khayyal SE, Girgis AN. TLC-Spectrophotometric assay of the main glycosides of Red Squill, A specific rodenticide. Journal of Natural product.1979;42:522-524

9- چارلز اوانس ویلیام . فارماکوگنوزی تریز و اوانس، دکتر سلیمان افشاری پور. دانشگاه علوم پزشکی اصفهان؛1386. جلد دوم.صص.254-255

10- زرگری، ع. گیاهان دارویی. تهران: مؤسسه انتشارات و چاپ دانشگاه تهران؛ 1390. جلدچهارم. ص. 702،703، 658،659

11- Khare CP. Indian medicinal plants. Berlin: Springer, 2007:590.

12 -  Pohl TS,  Crouch NR,  Mulholland DR. Southern African Hyacinthaceae: Chemistry, Bioactivity and Ethnobotany. Current Organic Chemistry.2000;(4):1287-1324

13- مظفریان، ولی الله ، شناخت گیاهان دارویی و معطر ایران.تهران: انتشارات فرهنگ معاصر؛.258.1391

14- مظفریان، ولی الله، فلور خوزستان . مرکز تحقیقات منابع طبیعی و امور دام خوزستان؛ 1390.

 جلد اول. ص 186

15 -Cogne AL, Marston  A, Mavi  S, Hostettmann K. Study of two plants used in traditional medicine in Zimbabwe for skin problems and rheumatism: Dioscoreasylvatica and Urginea altissima. J Ethnopharmacol 2001; 75(1): 51-53.

16-Pohl T, Koorbanally C, Crouch NR, Mulholland DA. Bufadienolides from Drimia robusta and Urginea altissima (Hyacinthaceae). Phytochemistry 2001; 58 (4): 557-561.

17-Abdillahi HS, Staden JV. South African plants and male reproductive healthcare: Conception and contraception. J Ethnopharmacol 2012; 143(2), 475-480.

18-Koorbanally NA, Koorbanally C, Harilal A, Mulholland DA, Crouch NR. Bufadienolides from Drimiarobusta and Urgineaepigea (Hyacinthaceae). Phytochemistry 2004; 65(23): 3069-3073

19-Aston Philander L, An ethnobotany of Western Cape Rasta bush medicine. J Ethnopharmacol 2011; 138(2): 578-594.

20-Koorbanally NA, Koorbanally C, Harilal A, Mulholland DA, Crouch NR. Bufadienolides from Drimiarobusta and Urgineaepigea (Hyacinthaceae). Phytochemistry 2004; 65(23): 3069-3073

21-Du Toit K, Elgorashi EE, Malan SF, Mulholland DA, Drewes  SE, Van Staden J. Antibacterial activity and QSAR of homoisoflavanones isolated from six Hyacinthaceae species. S Afr J Bot 2007; 73(2): 236-241.

22-Crouch NR, Du Toit K, Mulholland DA, Drewes SE. Bufadienolides from bulbs of Urginealydenburgensis (Hyacinthaceae: Urgineoideae). Phytochemistry 2006; 67(19): 2140-2145.

23-Fennell CW, Light ME, Sparg SG, Stafford GI, VanStaden J. Assessing African medicinal plants for efficacy and safety: agricultural and storage practices. J Ethnopharmacol 2004; 95(2-3): 113-121.

24-Louw CAM, Regnier TJC, Korsten L. Medicinal bulbous plants of South Africa and their traditional relevance in the control of infectious diseases. J Ethnopharmacol 2002; 82(2-3): 147-154.

25-Ndhlala AR, Finnie JF, VanStaden J. Plant composition, pharmacological properties and mutagenic evaluation of a commercial Zulu herbal mixture: Imbizaephuzwato. J Ethnopharmacol 2011; 133(2): 663-674.

26-Aston Philander L, An ethnobotany of Western Cape Rasta bush medicine. J Ethnopharmacol 2011; 138(2): 578-594.

27- Katewa SS, Chaudhary BL, Jain A. Folk herbal medicines from tribal area of Rajasthan, India. J Ethnopharmacol 2004; 92(1): 41-46.

28-Kala CP. Aboriginal uses and management of ethnobotanical species in deciduous forests of Chhattisgarh state in India. J Ethnobiol Ethnomed 2009; 5: 1-9.

29-Jain A, Katewa SS, Galav PK, Sharma P. Medicinal plant diversity of Sitamata wildlife sanctuary, Rajasthan, India. J Ethnopharmacol 2005; 102(2): 143-157.

30-Choudhary K, Singh M, Phillai U. Ethnobotanical Survey of Rajasthan - An Update. American-Eurasian J Bot 2008; 1: 38-45.

31-Swarnkar S, Katewa SS. Ethnobotanical observation on tuberous plants from tribal area of Rajasthan (India). Ethnobot Leaflets 2008; 12: 647-666.

32- Abbas S, Bashir S, Khan A, Mehmood MH, Gilani AH. Gastrointestinal stimulant effect of UrgineaindicaKunth. and involvement of muscarinic receptors. Phytother Res 2012; 26(5): 704-708.

33- Moodley N, Crouch NR, Mulholland DA. Bufadienolides from Drimia macrocentra and Urgineariparia (Hyacinthaceae: Urgineoideae). Phytochemistry 2007; 68(19): 2415-2419.

34-Marx J, Pretorius E, Espag WJ, Bester MJ. Urgineasanguinea: medicinal wonder or death in disguise? Environ Toxicol Pharmacol 2005; 20(1): 26-34.

35-Louw CAM, Regnier TJC, Korsten L. Medicinal bulbous plants of South Africa and their traditional relevance in the control of infectious diseases. J Ethnopharmacol 2002; 82(2-3): 147-154.

36-Al-Qura’n S. Ethnopharmacological survey of wild medicinal plants in Showbak, Jordan. J Ethnopharmacol 2009; 123(1): 45-50.

37-Afifi-Yazar FU, Kasabri V, Abu-dahab R. Medicinal Plants from Jordan in the Treatment of Cancer: Traditional Uses vs. In vitro and In vivo Evaluations – Part 1. Planta Med 2011; 77:1203–1209.

38-Owczarek K. Treating epilepsy: A review of Polish historical sources. Epilepsy Behav 2011; 22(2): 226-230.

39-Benítez G, González-Tejero MR, Molero-Mesa, J. Pharmaceutical ethnobotany in the western part of Granada province (southern Spain): Ethnopharmacological synthesis. J Ethnopharmacol 2010; 129(1): 87-105.

40-El-Seedi HR, [et al]. The traditional medical uses and cytotoxic activities of sixty-one Egyptian plants: Discovery of an active cardiac glycoside from Urgineamaritima. J Ethnopharmacol 2013; 145(3): 746-757.

41-Sayed MD. Traditional medicine in health care. J Ethnopharmacol 1980; 2(1): 19-22.

42-Adams M, Berset C, Kessler M, Hamburger M. Medicinal herbs for the treatment of rheumatic disorders—A survey of European herbals from the 16th and 17th century. J Ethnopharmacol 2009; 121(3): 343-359.

43-Leto C, Tuttolomondo T, La Bella S, Licata M. Ethnobotanical study in the Madonie Regional Park (Central Sicily, Italy)—Medicinal use of wild shrub and herbaceous plant species. J Ethnopharmacol 2013; 146(1): 90-112.

44-Cavallo P, Proto MC, Patruno C, Sorbo AD, Bifulco M. The first cosmetic treatise of history. A female point of view. Int J Cosmet Sci, 2008; 30(2): 79-86.

45- Marc EB, Nelly A, Annick DD, Frederic D. Plants used as remedies antirheumatic and antineuralgic in the traditional medicine of Lebanon. J Ethnopharmacol 2008;120(3): 315-334.

46- Saganuwan AS. Tropical plants with antihypertensive, antiasthmatic, and antidiabetic value. J Herbs, Spices Med Plants 2009; 15(1): 24-44.

47-Sezik E, YeŞilada E, Honda G, Takaishi Y, Takeda Y, Tanaka T. Traditional medicine in Turkey X. Folk medicine in Central Anatolia. J Ethnopharmacol 2001; 75(2-3): 95-115.

48-El-Hilaly J, Hmammouchi M, Lyoussi B. Ethnobotanical studies and economic evaluation of medicinal plants in Taounate province (Northern Morocco). J Ethnopharmacol 2003; 86(2-3): 149-158.

49-جرجیانی، سید اسماعیل. ذخیره خوارزمشاهی.تصحیح دکترمحمدرضا محرری. تهران:انتشارات فرهنگستان علوم پزشکی جمهوری اسلامی ایران؛1384.کتاب چهارم و پنجم.ص.111.

50- عقیلی،محمد حسین. قرابادیان کبیر.تهران: موسسه تاریخ پزشکی، اسلامی و طب مکمل؛ 2008 .ص. 530-544

51- عقیلی.مخزن الدویه.ویرایش شده توسط رحیمی،شمس اردکانی،فرجادمند. تهران:انتشارات دانشگاه علوم پزشکی تهران؛ 2009 . ص 146-147  

52- Fouche G, Cragg GM, Pillay P, Kolesnokova N, Maharaj VJ, Senabe J. In vitro anticancer screening of South African plants. J Ethnopharmacol 2008; 119(3): 455-461.

53-Baskaran P, Singh S, VanStaden J. In vitro propagation, ProscillaridinA production and antibacterial activity in Drimia robusta. Plant Cell Tiss Org 2013; 1-9  

54-Ndhlala AR, Finnie JF, VanStaden J. Plant composition, pharmacological properties and mutagenic evaluation of a commercial Zulu herbal mixture: Imbizaephuzwato. J Ethnopharmacol 2011; 133(2): 663-674.

55-Duncan AC, Jäger AK, VanStaden J. Screening of Zulu medicinal plants for angiotensin converting enzyme (ACE) inhibitors. J Ethnopharmacol 1999; 68(1-3): 63-70.

56-Deepak AV, Salimath BP. Antiangiogenic and proapoptotic activity of a novel glycoprotein from U-indica is mediated by NF-kB and Caspase activated DNase in ascites tumor model. Biochimie 2006; 88(3-4): 297-307.

57-Thatoi HN, Panda  SK, Rath  SK, Dutta SK. Antimicrobial activity and ethnomedicinal uses of some medicinal plants from Similipal Biosphere Reserve, Orissa. Asian J Plant Sci 2008; 7(3): 260-267.

58-Shenoy SR, Kameshwari MNS, Swaminathan S, Gupta MN. Major antifungal activity from the bulbs of Indian squillUrgineaindica is a chitinase. Biotechnol Prog 2006; 22(3): 631-637.

59-Tripathi YB, Singh  AV, Dubey GP. Antioxidant property of the bulb of Scilla indica. Curr Sci 2001; 80: 1267-1269.

60-Bashir S, Abbas S, Khan A, Gilani AH. Studies on bronchodilator and cardiac stimulant activities of Urginea indica. Bangladesh J Pharmacol 2013; 8: 249-254

61- Marx J, Pretorius E, Bester MJ. Effects of Urginea sanguinea, a traditional asthma remedy, on embryo neuronal development. J Ethnopharmacol 2006; 104(3): 315-321.

62- Naidoo V, Katerere DR, Swan GE, Eloff  JN. Pretreatment of Urginea sanguinea Bulbs Used in Ethnoveterinary Medicine Influences Chemical Composition and Biological Activity. Pharm biol 2004; 42(7): 529-533.

63- Polat, M., P. Oztas, [et al]. Contact dermatitis as a result of Urginea maritima. Contact Dermatitis 2007; 57(5).

64- Mammadov R, Makasc-Afacan, Uysal-demir, Derya;Gork, cigden. Determination of antioxidant activities of different Urginea maritima (L) baker plant extracts. Iran.J.Chem.Chem.Eng. 2010; 29(3): 47-53  

65- Vahdettin Bayazit, Vahit Konar. Analgesic effects of scilliroside, Proscillaridin-and Toxifolin from Squill bulb on pains. Digest Journal of Nanomaterials and Biostructures. 2010. 5(2).457-465

66- Giannopoulos, S. "Urginea maritima alcohol extract as hair toic for treatment of seborrhea. Ger.Offen, US Appl.1977.

67- Mert Metin,Betul Burun. Effects of the high dose of Urginea maritima L Baker extract on chromosoms.CARYOLOGIA. 2010.6(4).367-375 

68- Anthony J .verbiscar, Jagjivanbhai Patel, Thomas F.Banigan,Robert A.Schatz . Scilliroside and other scliia compounds in Red Squill. J.Agric.food Chem.1986. 34. 973-979

69-Climenko DR. Pharmacodynamics of the cardioactive principles of Urginea maritima (squill). J Am Pharm Assoc 1938; 27: 596-603.

70-Stoll A, Suter E, Kreis W, Bussemaker BB, Hofmann A. Die herzaktiven Substanzen der Meerzwiebel. Scillaren A. Helv Chim Acta 1933; 16: 703-733.

71-Vaklavas C, Chatzizisis YS, Tsimberidou AM. Common cardiovascular medications in cancer therapeutics. Pharmacol Ther 2011;130(2):177-190.

72-Prassas I, Diamandis EP. Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov 2008; 7(11):926-935.

73-Gao H, Popescu R, Kopp B, Wang Z. Bufadienolides and their antitumor activity. Nat Prod Rep 2011; 28(5): 953-969.

74-Krenn L, Kopp B. Bufadienolidesfrom animal and plant sources. Phytochemistry 1998; 48(1): 1-29.

75-Tittel G, Wagner H. Qualitative und quantitative Analyse von Herzglykosiddrogen durch HPLC-Verfahren. Planta Med 1980; 39(6): 125-134.

76-Kopp B, Jurenitsch J, Czernia B, Kubelka W. Separation of cardiac glycosides of Urginea maritima by high-performance liquid chromatography; improvement by serial coupling of several polar reversed phase columns. J Chromatogr 1983; 257: 137-139.

77-Verbiscar  AJ, Patel J, Banigan TF, Schatz  RA. Scilliroside and other scilla compounds in red squill. J Agric food chem 1986;34: 973-979

78- Wagner H. Plant drug analysis: a thin layer chromatography atlas. Berlin:Springer, 1996:122

79-Steyn PS, Van Heerden FR. Bufadienolides of plant and animal origin. Nat Prod Rep 1998; 15: 397-413.

80-Vega FA, Fernandez M, Casado PG, Esteruelas ME. Separation of cardiotonic from flavanoid compounds of the squill, Urginea maritima Baker. Experientia 1969;25(4): 447-8

81-Krishna Rao RV, Devi  V. Sterols from South India Squill. Naturwissenschaften 1964;51: 511.

82-Crabtree DG. Red squill-most specific of the raticides. Econ Bot 1947; 1: 394-401.

83-Spies T, Praznik W, Hofinger A, Altmann F, Nitsch E, Wutka R. The structure of the fructan sinistrin from Urginea maritima. Carbohydr Res 1992;235: 221-230.

84-Praznik W, Spies T. Fructo-oligosaccharides from Urginea maritima. Carbohydr Res 1993;243(1): 91-97.

85-Hassid E, Applebaum SW,  Birk  Y. Azetidine-2-carboxylic acid: a naturally occurring inhibitor of Spodoptera littoralis  (Boisd) (Lepidoptera: Noctuidae). Phytoparasitica 1976; 4: 173-183.

86-Leblanc FJ,  Lee  CO. A study of toxic principles of red squill. J Am Pharm Assoc 1939; 28: 151-154

87-Deepak AV, Thippeswamy G, Shivakameshwari MN, Salimath BP. Isolation and characterization of a 29-kDa glycoprotein with antifungal activity from bulbs of Urginea indica. Biochem Biophys Res Commun 2003; 311(3): 735-742.

88- Gaidamashvili  M, VanStaden J. Prostaglandin inhibitory activity by lectin-like proteins from South African medicinal plants. S Afr J Bot 2006; 72(4): 661-663.

89-Krenn L, Kopp B, Bamberger M, Brustmann E, Kubelka W. Bufadienolides and a Steroidal Sapogenin from Urginea sanguinea (Hyacynthaceae). Nat Prod Lett 1993; 3(2):139-143.

90-Gould L, Fisch S, Cherbakoff A, Degraff AC. Clinical studies on Proscillaridin, a new squill glycoside. J clin pharmacol new drugs 1971; 11(2): 135-145.

91-Belz GG, Schreiter H, Wolf GK. Pharmacokinetics and pharmacodynamics of methyl Proscillaridin in healthy man. Eur J clin pharmacol 1976; 10: 101-108.

92-Andersson KE, Bergdahl B. Pharmacokinetics of squill glycosides. In:Greef K. handbook of experimental pharmacology: Cardiac glycosides. Berlin: Springer 1981;56: 87-94.

93-Schneider R, [et al]. Proscillaridin A immunoreactivity: Its purification, transport in blood by a specific binding protein and its correlation with blood pressure. Clin Exp Hypertens 1998; 20:593-599.

94-کلیرلکند اشنایدر. کروماتوگرافی مایع با کارایی بالا (HPLC). ترجمه عباس شجاع الساداتی. تهران: انتشارات دانشگاه تربیت مدرس؛ 1371. ص1-130

95- شفیعی، ع. تجزیه داروها در مایعات زیستی. تهران: انتشارات دانشگاه تهران؛ 1375. ص38-33

96- لیندسی سندی. کروماتوگرافی مایع با بازدهی عالی. ترجمه حسین سالار آملی. تهران: انتشارات دانشگاه تهران؛ 1375. ص1-150

97-Hamilton RI., Sewell PA. Introduction to high performance liquid chromatography. 2nd edition. New York: chapman f Hall; 1981. p. 42-49

98- Ravindranath B. Principles and practice of chromatography . New York: Ellis Horwood limited; 1981. p. 295-325

99- Dennis J. Maintaining and troubleshooting HPLC systems. A wiley interscience publication; 1981. p. 1-100

100- ICH Q2A & Q2B (International Conference of Harmonisation), Validation of analytical proc. 1995

101- Tittel G, Wagner H. Qualitative und quantitative Analyse von Herzglykosiddrogen durch HPLC-Verfahren. Planta Med 1980; 39(6): 125-134.

102-Dinan L, Haramatha J, Lafont R. Chromatographic procedures for the isolation of plant steroids. J. Chromatogr. A. 2001; 935: 105-123.